AstraZeneca_NN
Annual_JJ
Report_NN
and_CC
90_CD
Form_NN
20-F_JJ
Information_NOMZ
2005_CD
NOTES_NN
TO_PIN
THE_DT
FINANCIAL_NN
STATEMENTS_NOMZ
1_CD
OPERATING_GER
PROFIT_NN
2005 2004 2003_CD
$_$
m_CD
$_$
m_CD
$_$
m_CD
Group_NN
operating_GER
profit_NN
6,502_CD
4,547_CD
4,007_CD
Charges_NN
included_VBD
above_PLACE
for_PIN
depreciation_NOMZ
965 921 990_CD
for_PIN
amortisation_NOMZ
272 306 296_CD
for_PIN
impairment_NOMZ
90_CD
41_CD
7_CD
Gross_NN
profit_NN
18,594_CD
16,233_CD
14,386_CD
Impairment_NOMZ
charges_NN
in_PIN
2005_CD
relate_VPRT
to_PIN
the_DT
write-down_NN
of_PIN
assets_NN
associated_VBN [WZPAST]
with_PIN
capacity_NOMZ
reviews_NN
at_PIN
manufacturing_VBG
sites_NN
,_,
primarily_RB
in_PIN
the_DT
UK_NN
and_PHC
France_NN
._.
Cost_NN
of_PIN
sales_NN
in_PIN
2004_CD
includes_VPRT
charges_NN
against_PIN
inventories_NN
and_PHC
prepayments_NOMZ
in_PIN
respect_NN
of_PIN
Exanta_NN
and_PHC
Iressa_NN
totalling_VBG [WZPRES]
$_$
195m_CD
._.
In_CONJ
addition_NULL
,_,
the_DT
charge_NN
for_PIN
impairment_NOMZ
in_PIN
2004_CD
arose_VBD
from_PIN
writing_VBG [PUBV]
off_PIN
property_NN
,_,
plant_NN
and_PHC
equipment_NOMZ
and_PHC
goodwill_NN
associated_VBN [WZPAST]
with_PIN
Exanta_NN
and_PHC
Iressa_NN
._.
2005 2004 2003_CD
$_$
m_CD
$_$
m_CD
$_$
m_CD [BEMA]
Other_JJ
operating_GER
income_NN
Royalties_NN
165_CD
95_CD
90_CD
Other_JJ
income_NN
28_CD
131 98 193 226_CD
188_CD
Other_JJ
income_NN
includes_VPRT
minor_JJ
gains_NN
and_PHC
losses_NN
arising_VBG [WZPRES]
from_PIN
disposals_NN
under_IN
ongoing_JJ
product_NN
and_PHC
investment_NOMZ
rationalisation_NOMZ
programs_NN
._.
2_CD
PROFIT_NN
ON_PIN
SALE_NN
OF_PIN
INTEREST_NN
IN_PIN
JOINT_NN
VENTURE_NN
2005 2004 2003_CD
$_$
m_CD
$_$
m_CD
$_$
m_CD
Profit_NN
on_PIN
sale_NN
of_PIN
interest_NN
in_PIN
joint_JJ
venture_NN
219_CD
Net_JJ
taxation_NOMZ
credit_NN
9_CD
Total_JJ
profit_NN
on_PIN
sale_NN
of_PIN
interest_NN
in_PIN
joint_JJ
venture_NN
after_IN
taxation_NOMZ
228_CD
The_DT
profit_NN
on_PIN
sale_NN
of_PIN
interest_NN
in_PIN
joint_JJ
venture_NN
relates_VPRT
to_PIN
the_DT
disposal_NN
of_PIN
the_DT
Groups_NN
interest_NN
in_PIN
the_DT
Ordinary_NN
Share_NN
capital_NN
of_PIN
Advanta_NN
BV_NN
._.
There_EX
is_VPRT
a_DT
tax_NN
credit_NN
of_PIN
$_$
9m_CD
arising_VBG
on_PIN
costs_NN
associated_VBN [WZPAST]
with_PIN
the_DT
disposal_NN
._.
3_CD
FINANCE_NN
INCOME_NN
AND_PHC
EXPENSE_NN
2005 2004 2003_CD
$_$
m_CD
$_$
m_CD
$_$
m_CD
Finance_NN
income_NN
Securities_NOMZ
15_CD
10_CD
21_CD
Short_JJ
term_NN
deposits_NN
197_CD
81_CD
62_CD
Expected_VBN [PRIV]
return_NN
on_PIN
post-employment_NOMZ
defined_VBN
benefit_NN
plan_NN
assets_NN
448 390 277_CD
Gain_NN
on_PIN
disposal_NN
of_PIN
interest_NN
rate_NN
swap_NN
30_CD
Dividend_NN
income_NN
62_CD
Net_JJ
exchange_NN
gains_NN
5_CD
15 19 665 532_CD
381_CD
Finance_NN
expense_NN
Loan_NN
interest_NN
42_CD
29_CD
6_CD
Interest_NN
on_PIN
short_JJ
term_NN
borrowings_GER
and_CC
other_JJ
financing_GER
costs_NN
19_CD
17_CD
6_CD
Discount_NN
on_PIN
liability_NOMZ
3_CD
Interest_NN
on_PIN
post-employment_NOMZ
defined_VBN
benefit_NN
plan_NN
liabilities_NOMZ
433 398 284_CD
Fair_NN
value_NN
losses_NN
on_PIN
interest_NN
rate_NN
swaps_NN
6_CD
10 12 500 454_CD
311_CD
Net_NN
finance_NN
income_NN
165_CD
78_CD
70_CD
The_DT
amount_NN
of_PIN
exchange_NN
gains_NN
recognized_VBN [PRIV] [WZPAST]
in_PIN
profit_NN
or_CC
loss_NN
,_,
other_JJ
than_PIN
those_DEMP
arising_VBG
on_PIN
financial_JJ
instruments_NOMZ
measured_VBN [WZPAST]
at_PIN
fair_JJ
value_NN
through_PIN
profit_NN
or_CC
loss_NN
in_PIN
accordance_NN
with_PIN
IAS_NN
39_CD
see_VPRT [PRIV]
Note_VB [PRIV]
15_CD
,_,
is_VPRT
$_$
5m_CD
2004_CD
$_$
15m_CD
,_,
2003_CD
$_$
19m_CD
._.
